Peripheral Nerve Injections for CRPS

Complex Regional Pain Syndromes Clinical Trial

Official title:

Peripheral Nerve Injections for the Treatment of Upper Extremity Complex Regional Pain Syndrome: A Feasibility Study for a Proposed Randomized Design

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04744675
• Other study ID #: 20200600-01H
• Status: Not yet recruiting
• Phase: Phase 4
• Start date: March 2021
• Est. completion date: March 2023

Study information

• Verified date: February 2021
• Source: Ottawa Hospital Research Institute
• Contact: Katherine Reilly, MSc
• Phone: (613) 562 5800
• Email: kreilly[@]ohri.ca
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Background Complex regional pain syndrome (CRPS) is characterized by intense pain and loss of function, and associated with motor, trophic, sudomotor, and/or vasomotor changes of the affected extremity. CRPS of the upper extremity is seen frequently in our electrodiagnostic, neurology, and musculoskeletal clinics and occurs in up to one-third of patients who have undergone common surgical procedures, such as carpal tunnel release or release of Dupuytren's contracture. To date, there is a limited understanding of the underlying pathophysiology of CRPS. As a consequence, few effective treatment options are available. Peripheral nerve blocks have proven to be successful in reducing pain for several musculoskeletal and neurologic conditions. These blocks could be an opportunity for blocking somatic and autonomic sensory fibers that are thought to contribute to CRPS. In a small exploratory study, we found that peripheral nerve blocks in the upper extremity (suprascapular and median nerves) resulted in a 56% and 37% pain reduction in the shoulder and hand two weeks after injection, respectively, and were well-tolerated in patients with CRPS. While this was highly encouraging, large randomized placebo-controlled trials (RCTs) are necessary to demonstrate effectiveness and safety of nerve blocks for this population before this treatment is accepted into clinical practice. This proposal aims to demonstrate the feasibility of performing such a RCT. Objective To evaluate the feasibility of performing a placebo-controlled RCT assessing the efficacy and safety of peripheral nerve blocks (suprascapular, median, and ulnar nerves) for reducing pain in patients with CRPS. This is a phase IV feasibility study that will test the critical elements necessary for performing a RCT. Methods We will recruit participants (≥18 years old) from The Ottawa Hospital, Bruyère Continuing Care (Elisabeth Bruyère Hospital, St-Vincent Hospital), and Providence Care Hospital (Kingston, ON), meeting the well-established clinical Budapest criteria for upper extremity CRPS and having a visual analog scale (VAS) pain score of at least 40 mm (to avoid flooring effect). Participants will be block-randomized by the Ottawa Methods Centre to receive injections of either A) intervention (suprascapular, median, and ulnar nerves) with bupivacaine and triamcinolone acetonide, or B) placebo (saline). All participants will receive standard care for CRPS. Feasibility outcomes will focus on crucial methodologic aspects for the future RCT, including: (1) level of recruitment, (2) rate of acceptance from eligible patients to the randomization procedure, (3) blinding efficacy, (4) degree of patient retention, (5) rate of data completion, and (6) rate of adverse events for both the placebo and intervention groups. Outcome measures will be evaluated within 1 hour, 2 weeks, 6 weeks, and 3 months post-injection.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: March 2023
• Est. primary completion date: October 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Able to provide signed and dated informed consent form

2. Male or female, aged =18 years old

3. Satisfy the Budapest Criteria for upper extremity CRPS

4. A VAS score of at least 40 mm in the upper extremity to avoid flooring effect for injection-related pain reduction

Exclusion Criteria:

1. Uncontrolled hypertension (>180/110)

2. Sepsis

3. Bleeding diathesis

4. Active cancer

5. Brachial plexus injuries

6. Neurological language deficits precluding participation

7. Mini mental state examination score < 23

8. Acute mental illness (An acute mental illness is characterized by clinically significant symptoms of any metal health illness that requires immediate treatment. The physician making the recommendation to be part of the study. If the patient exhibits symptoms of any mental health illness that is not being treated by either the recommending physician or another member of the patient's care team the patient will not be recommended to participate in the study)

9. Patients who are pregnant or breastfeeding

Related Conditions & MeSH terms

• Complex Regional Pain Syndromes
• Reflex Sympathetic Dystrophy
• Syndrome

Intervention

Drug:
• Triamcinolone Acetonide 40mg/mL
Triamcinolone acetonide is a synthetic glucocorticoid corticosteroid with marked anti-inflammatory action, in a sterile aqueous suspension suitable for intramuscular, intra-articular, and intrabursal injection.
• Saline Injection
Saline is a buffer solution commonly used in biological research. It is a water-based salt solution containing disodium hydrogen phosphate, sodium chloride and, in some formulations, potassium chloride and potassium dihydrogen phosphate. The buffer helps to maintain a constant pH. The osmolarity and ion concentrations of the solutions match those of the human body.

Locations

Country	Name	City	State
Canada	Elisabeth Bruyere Hospital	Ottawa	Ontario
Canada	The Ottawa Hospital	Ottawa	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
Ottawa Hospital Research Institute

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Recruitment	Number of participants who are successfully recruit into the study.	Week -2
Primary	Randomization	Number of participants who accept being randomized into either the intervention or placebo treatment arms and receive the injection accordingly.	Week 0
Primary	Blinding - Participant	The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).	Week 0
Primary	Blinding - Participant	The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).	Week 2
Primary	Blinding - Participant	The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).	Week 6
Primary	Blinding - Participant	The participants will be asked which arm they believe they are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).	Week 12
Primary	Blinding - Interventionist	The interventionist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).	Week 0
Primary	Blinding - Physiotherapist	The physiotherapist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).	Week 2
Primary	Blinding - Physiotherapist	The physiotherapist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).	Week 6
Primary	Blinding - Physiotherapist	The physiotherapist will be asked which arm they believe the participant is are part of and this response will be compared to their actual group allocation. The level of agreement between the actual group allocation and the guess provided will be compared using Bang's blinding index, we will consider blinding effective if the index is between -0.2 and 0.2 (zero being perfect blinding).	Week 12
Primary	Retention	The percentage of participants who remained in the study for the entire duration of their planned involvement.	Week 12
Primary	Data completion	The percentage of participants who complete all of the study questionnaires	Week 12
Primary	Rate of Adverse events	We will track adverse events the participants experience	Week 12
Secondary	Pain - Visual Analog Scale	We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant	Week -2
Secondary	Pain - Visual Analog Scale	We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant	Week 0 - Immediately before injection
Secondary	Pain - Visual Analog Scale	We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant	Week 0 - Immediately after injection
Secondary	Pain - Visual Analog Scale	We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant	Week 2
Secondary	Pain - Visual Analog Scale	We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant	Week 6
Secondary	Pain - Visual Analog Scale	We will track the pain experienced by the participants on a visual analog scale. The lowest score is 0 the highest score is 10. A higher value indicates a higher amount of pain experienced by the participant	Week 12
Secondary	Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.	Week -2
Secondary	Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.	Week 0
Secondary	Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.	Week 2
Secondary	Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.	Week 6
Secondary	Pain - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 4 and the highest possible score is 30, and a higher score indicates a worse outcome.	Week 12
Secondary	Pain - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week -2
Secondary	Pain - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 0
Secondary	Pain - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 2
Secondary	Pain - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 6
Secondary	Pain - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 12
Secondary	Disease Severity - Complex Regional Pain Syndrome Severity Score	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.	Week -2
Secondary	Disease Severity - Complex Regional Pain Syndrome Severity Score	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.	Week 0
Secondary	Disease Severity - Complex Regional Pain Syndrome Severity Score	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.	Week 2
Secondary	Disease Severity - Complex Regional Pain Syndrome Severity Score	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.	Week 6
Secondary	Disease Severity - Complex Regional Pain Syndrome Severity Score	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 17, and a higher score indicates a worse outcome.	Week 12
Secondary	Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.	Week -2
Secondary	Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.	Week 0
Secondary	Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.	Week 2
Secondary	Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.	Week 6
Secondary	Function - Disabilities of the Arm, Shoulder, and Hand Questionnaire	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 0 and the highest possible score is 100, and a higher score indicates a worse outcome.	Week 12
Secondary	Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.	Week -2
Secondary	Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.	Week 0
Secondary	Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.	Week 2
Secondary	Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.	Week 6
Secondary	Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 8 and the highest possible score is 40, and a higher score indicates a better outcome.	Week 12
Secondary	Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.	Week -2
Secondary	Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.	Week 0
Secondary	Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.	Week 2
Secondary	Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.	Week 6
Secondary	Emotional and Psychological Function - Patient-Reported Outcomes Measurement Information System 29 Profile V2	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 16 and the highest possible score is 80, and a higher score indicates a worse outcome.	Week 12
Secondary	Emotional and Psychological Function - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week -2
Secondary	Emotional and Psychological Function - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 0
Secondary	Emotional and Psychological Function - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 2
Secondary	Emotional and Psychological Function - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 6
Secondary	Emotional and Psychological Function - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 12
Secondary	Quality of Life - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week -2
Secondary	Quality of Life - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 0
Secondary	Quality of Life - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 2
Secondary	Quality of Life - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 6
Secondary	Quality of Life - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 1 and the highest possible score is 5, and a higher score indicates a worse outcome.	Week 12
Secondary	Total Score - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.	Week -2
Secondary	Total Score - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.	Week 0
Secondary	Total Score - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.	Week 2
Secondary	Total Score - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.	Week 6
Secondary	Total Score - EQ-5D-5L	These outcomes will allow us to better understand the holistic effect of the intervention. The lowest possible score is 5 and the highest possible score is 25, and a higher score indicates a worse outcome.	Week 12